AP2007004040A0 - Pyridazinone compounds - Google Patents

Pyridazinone compounds

Info

Publication number
AP2007004040A0
AP2007004040A0 AP2007004040A AP2007004040A AP2007004040A0 AP 2007004040 A0 AP2007004040 A0 AP 2007004040A0 AP 2007004040 A AP2007004040 A AP 2007004040A AP 2007004040 A AP2007004040 A AP 2007004040A AP 2007004040 A0 AP2007004040 A0 AP 2007004040A0
Authority
AP
ARIPO
Prior art keywords
pyridazinone compounds
pyridazinone
compounds
Prior art date
Application number
AP2007004040A
Other languages
English (en)
Inventor
Liansheng Li
Stephen Evan Webber
Yuefen Zhou
Original Assignee
Anadys Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anadys Pharmaceuticals Inc filed Critical Anadys Pharmaceuticals Inc
Publication of AP2007004040A0 publication Critical patent/AP2007004040A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AP2007004040A 2004-12-17 2005-12-16 Pyridazinone compounds AP2007004040A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63661604P 2004-12-17 2004-12-17
PCT/US2005/045588 WO2006066079A2 (en) 2004-12-17 2005-12-16 Pyridazinone compounds

Publications (1)

Publication Number Publication Date
AP2007004040A0 true AP2007004040A0 (en) 2007-06-30

Family

ID=36588590

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2007004040A AP2007004040A0 (en) 2004-12-17 2005-12-16 Pyridazinone compounds

Country Status (21)

Country Link
US (1) US7425552B2 (xx)
EP (1) EP1824847A2 (xx)
JP (1) JP2008526687A (xx)
KR (1) KR20070100743A (xx)
CN (1) CN101137651A (xx)
AP (1) AP2007004040A0 (xx)
AR (1) AR054214A1 (xx)
AU (1) AU2005316396A1 (xx)
CA (1) CA2589527A1 (xx)
CR (1) CR9204A (xx)
EA (1) EA200701297A1 (xx)
GT (1) GT200500373A (xx)
IL (1) IL183510A0 (xx)
MX (1) MX2007007264A (xx)
NO (1) NO20073105L (xx)
PA (1) PA8657001A1 (xx)
PE (1) PE20060871A1 (xx)
SV (1) SV2006002347A (xx)
TW (1) TW200635596A (xx)
UY (1) UY29266A1 (xx)
WO (1) WO2006066079A2 (xx)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1824847A2 (en) 2004-12-17 2007-08-29 Anadys Pharmaceuticals, Inc. Pyridazinone compounds
EP2591784B1 (en) 2005-05-10 2016-09-14 Intermune, Inc. Pyridine-2-one-derivatives as modulators of stress-activated protein kinase system
US20080090814A1 (en) * 2006-06-22 2008-04-17 Anadys Pharmaceuticals, Inc. Pyridazinone compounds
JP5306194B2 (ja) * 2006-06-22 2013-10-02 アナディス ファーマシューティカルズ インク ピロ［１，２−ｂ］ピリダジノン化合物
WO2008073987A1 (en) * 2006-12-12 2008-06-19 Anadys Pharmaceuticals, Inc. Saturated fused [1,2-b] pyridazinone compounds
TW200840572A (en) 2006-12-12 2008-10-16 Anadys Pharmaceuticals Inc 5,6-dihydro-1H-pyridin-2-one compounds
US20080188466A1 (en) * 2006-12-21 2008-08-07 Anadys Pharmaceuticals, Inc. Pyridazinone compounds
WO2008082725A1 (en) * 2006-12-29 2008-07-10 Anadys Pharmaceuticals, Inc. Pyridazinone compounds
US20080227774A1 (en) * 2007-03-15 2008-09-18 Frank Ruebsam 5,5-disubstituted-indolizinone compounds
UA100120C2 (xx) 2007-04-03 2012-11-26 Анадис Фармасьютикалз, Инк. Сполуки 5,6-дигідро-1h-піридин-2-ону$соединения 5, дигидро-1 пиридин-2-она
EP2494991A1 (en) 2007-05-04 2012-09-05 Vertex Pharmaceuticals Incorporated Combination therapy for the treatment of HCV infection
WO2008144500A2 (en) * 2007-05-17 2008-11-27 Anadys Pharmaceuticals, Inc. 1-methyl-benzo[1,2,4]thiadiazine, 1-oxide derivatives
ITMI20071012A1 (it) * 2007-05-18 2008-11-19 St Microelectronics Srl Dispositivo di memoria migliorato a veloce programmazione
US7834009B2 (en) * 2007-08-27 2010-11-16 Anadys Pharmaceuticals, Inc. 4-hydroxy-5,6-dihydro-1H-pyridin-2-one compounds
CA2726588C (en) 2008-06-03 2019-04-16 Karl Kossen Compounds and methods for treating inflammatory and fibrotic disorders
CN102316871B (zh) 2008-06-10 2014-06-04 安那迪斯药品股份有限公司 [1，2，4]噻二嗪1，1-二氧化合物
TW201026675A (en) * 2008-10-09 2010-07-16 Anadys Pharmaceuticals Inc 5,6-dihydro-1H-pyridin-2-one compounds
TWI480272B (zh) 2008-10-09 2015-04-11 Anadys Pharmaceuticals Inc 藉由５，６－二氫－１ｈ－吡啶－２－酮與一或多種其他抗病毒化合物的組合物抑制ｃ型肝炎病毒的方法
WO2010082050A1 (en) 2009-01-16 2010-07-22 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. Macrocyclic and 7-aminoalkyl-substituted benzoxazocines for treatment of hepatitis c infections
WO2011045271A1 (de) 2009-10-15 2011-04-21 Bayer Cropscience Ag Herbizid wirksame heterocyclylsubstituierte pyridazinone
BR112012009796A2 (pt) 2009-10-28 2020-08-18 Anadys Pharmaceuticals, Inc. composto, métodos para tratar ou prevenir infecções por vírus da hepatite c em mamífero necessitado destes usos de composto e de composição farmacêutica.
WO2011072370A1 (en) 2009-12-18 2011-06-23 Boehringer Ingelheim International Gmbh Hcv combination therapy
WO2012158271A1 (en) 2011-04-06 2012-11-22 Anadys Pharmaceuticals, Inc. Bridged polycyclic compounds as antiviral agents
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
WO2014121418A1 (en) 2013-02-07 2014-08-14 Merck Sharp & Dohme Corp. Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c
WO2014121417A1 (en) 2013-02-07 2014-08-14 Merck Sharp & Dohme Corp. Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c
WO2014121416A1 (en) 2013-02-07 2014-08-14 Merck Sharp & Dohme Corp. Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c
EP3126362B1 (en) 2014-04-02 2022-01-12 Intermune, Inc. Anti-fibrotic pyridinones
KR102202242B1 (ko) * 2014-04-29 2021-01-13 에프엠씨 코포레이션 피리다지논계 제초제
WO2017098952A1 (ja) * 2015-12-07 2017-06-15 Dic株式会社 重合性化合物の製造方法
CN105999097A (zh) * 2016-07-08 2016-10-12 王恩禄 一种治疗乙肝的中药组合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ504021A (en) * 1997-10-17 2003-04-29 Systemic Pulmonary Delivery Lt Method and apparatus for delivering aerosolized medication having air discharged through air tube directly into plume of aerosolized medication
JP2004509066A (ja) 2000-05-10 2004-03-25 スミスクライン・ビーチャム・コーポレイション 新規抗感染症薬
US20060003346A1 (en) 2000-08-11 2006-01-05 Ashok Amin Method for treating hepatitis
AR036081A1 (es) 2001-06-07 2004-08-11 Smithkline Beecham Corp Compuesto de 1,2-dihidroquinolina, su uso para preparar una composicion farmaceutica, metodos para prepararlo y compuestos del acido 2-aminobenzoico n-alquilado de utilidad como intermediarios en dichos metodos
AU2002365198A1 (en) 2001-10-30 2003-07-30 Smithkline Beecham Corporation Novel anti-infectives
US7601709B2 (en) 2003-02-07 2009-10-13 Enanta Pharmaceuticals, Inc. Macrocyclic hepatitis C serine protease inhibitors
US7439246B2 (en) 2004-06-28 2008-10-21 Bristol-Myers Squibb Company Fused heterocyclic kinase inhibitors
WO2006021340A1 (en) 2004-08-23 2006-03-02 F.Hoffmann-La Roche Ag Heterocyclic antiviral compounds
EP1824847A2 (en) 2004-12-17 2007-08-29 Anadys Pharmaceuticals, Inc. Pyridazinone compounds
AU2006240730A1 (en) 2005-04-21 2006-11-02 Nippon Shinyaku Co., Ltd. Phthalazinone derivative and pharmaceutical comprising the same
KR20070116682A (ko) * 2005-05-04 2007-12-10 에프. 호프만-라 로슈 아게 헤테로사이클릭 항바이러스성 화합물
JP5306194B2 (ja) 2006-06-22 2013-10-02 アナディス ファーマシューティカルズ インク ピロ［１，２−ｂ］ピリダジノン化合物

Also Published As

Publication number Publication date
CA2589527A1 (en) 2006-06-22
US20060189602A1 (en) 2006-08-24
NO20073105L (no) 2007-09-13
KR20070100743A (ko) 2007-10-11
MX2007007264A (es) 2007-08-14
JP2008526687A (ja) 2008-07-24
SV2006002347A (es) 2006-08-25
GT200500373A (es) 2006-10-02
PA8657001A1 (es) 2006-08-03
US7425552B2 (en) 2008-09-16
WO2006066079A3 (en) 2006-12-14
CR9204A (es) 2007-09-06
CN101137651A (zh) 2008-03-05
AU2005316396A1 (en) 2006-06-22
EP1824847A2 (en) 2007-08-29
AR054214A1 (es) 2007-06-13
UY29266A1 (es) 2006-07-31
WO2006066079A2 (en) 2006-06-22
TW200635596A (en) 2006-10-16
EA200701297A1 (ru) 2007-12-28
IL183510A0 (en) 2007-09-20
PE20060871A1 (es) 2006-09-04

Similar Documents

Publication Publication Date Title
AP2007004040A0 (en) Pyridazinone compounds
GB0405933D0 (en) Compounds
EP1737831A4 (en) NEUROLOGICALLY ACTIVE COMPOUNDS
GB0405937D0 (en) Compounds
GB0408995D0 (en) Compounds
EP1755617A4 (en) PERFLUORCARBON-SOLUBLE COMPOUNDS
GB0405193D0 (en) Compounds
GB0405272D0 (en) Compounds
GB0405267D0 (en) Compounds
GB0405101D0 (en) Compounds
GB0401269D0 (en) Compounds
GB0405280D0 (en) Compounds
GB0405893D0 (en) Compounds
GB0403593D0 (en) Compounds
GB0406916D0 (en) Compounds
GB0403595D0 (en) Compounds
GB0404081D0 (en) Compounds
GB0405194D0 (en) Compounds
GB0403990D0 (en) Compounds
GB0403594D0 (en) Compounds
GB0403993D0 (en) Compounds
GB0403334D0 (en) Compounds
GB0403998D0 (en) Compounds
GB0401657D0 (en) Compounds
GB0404083D0 (en) Compounds